VOYA Investment Management
GBT

VOYA Investment Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

VOYA Investment Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-24,727
Closed -$1.68M – 2981
2022
Q3 		$1.68M Sell
24,727
-56,913
-70% -$3.14M ﹤0.01% 1391
2022
Q2 		$2.61M Buy
81,640
+57,245
+235% +$1.68M 0.01% 993
2022
Q1 		$845K Buy
24,395
+936
+4% +$28K ﹤0.01% 1582
2021
Q4 		$687K Buy
23,459
+25
+0.1% +$774 ﹤0.01% 1808
2021
Q3 		$597K Hold
23,434
– – ﹤0.01% 1938
2021
Q2 		$821K Buy
23,434
+3,730
+19% +$146K ﹤0.01% 1789
2021
Q1 		$803K Sell
19,704
-1,222
-6% -$56.2K ﹤0.01% 1731
2020
Q4 		$906K Sell
20,926
-785
-4% -$38.7K ﹤0.01% 1566
2020
Q3 		$1.2M Sell
21,711
-119,485
-85% -$7.59M ﹤0.01% 1207
2020
Q2 		$8.91M Sell
141,196
-91,057
-39% -$6.25M 0.02% 568
2020
Q1 		$11.9M Buy
232,253
+15,902
+7% +$1.07M 0.03% 430
2019
Q4 		$17.2M Buy
216,351
+15,551
+8% +$922K 0.04% 420
2019
Q3 		$9.74M Sell
200,800
-32,274
-14% -$1.68M 0.02% 602
2019
Q2 		$12.3M Sell
233,074
-39,163
-14% -$2.25M 0.03% 544
2019
Q1 		$14.4M Sell
272,237
-83,381
-23% -$4.1M 0.03% 463
2018
Q4 		$14.6M Sell
355,618
-114,831
-24% -$4.3M 0.04% 444
2018
Q3 		$17.9M Buy
470,449
+450,823
+2,297% +$20M 0.04% 461
2018
Q2 		$887K Buy
19,626
+2,949
+18% +$134K ﹤0.01% 1451
2018
Q1 		$805K Sell
16,677
-15
-0.1% -$837 ﹤0.01% 1510
2017
Q4 		$657K Sell
16,692
-390
-2% -$14.6K ﹤0.01% 1676
2017
Q3 		$530K Hold
17,082
– – ﹤0.01% 1835
2017
Q2 		$467K Buy
17,082
+9,443
+124% +$281K ﹤0.01% 1876
2017
Q1 		$281K Buy
+7,639
New +$192K ﹤0.01% 2091

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

VOYA Investment Management's GBT Position: Q4 2022 in Review

VOYA Investment Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 24,727 shares — an estimated $1.68M sold.

VOYA Investment Management first reported a position in GBT in Q1 2017 and held it in 23 quarters. The position peaked at $17.9M in Q3 2018. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • VOYA Investment Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • VOYA Investment Management sold 24,727 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $1.68M.
  • VOYA Investment Management first reported a position in Global Blood Therapeutics, Inc. in Q1 2017 and held it in 23 quarters.
  • VOYA Investment Management's Global Blood Therapeutics, Inc. position peaked at $17.9M in Q3 2018.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on VOYA Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.